Consistent with those data, we found by immunoblotting and cell proliferation assays that in MEK1T55delinsRT-expressing melanoma cells, normalization of p-ERK levels by moderate BRAF or ERK inhibitor treatment rescued the cytostatic activity of hyperactivated MAPK signaling (Fig4G, Supplementary Figs S3–S5). Here, BRAF is linked to melanoma.